DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$56.1B
1-Year Return
19.33%
This Quarter Return
+11.9%
1 Year Return
+19.33%
3 Year Return
+93.16%
5 Year Return
+155.59%
10 Year Return
+349.91%
AUM
$48.7B
AUM Growth
+$5.31B
(+12%)
Cap. Flow
+$797M
Cap. Flow
% of AUM
1.64%
Top 10 Holdings %
Top 10 Hldgs %
24.57%
Holding
1,558
New
71
Increased
554
Reduced
469
Closed
82
Top Buys
| 1 |
XRTX
XORTX Therapeutics
XRTX
|
+$161M |
| 2 |
Broadcom
AVGO
|
+$136M |
| 3 |
Union Pacific
UNP
|
+$96.5M |
| 4 |
Chevron
CVX
|
+$94.1M |
| 5 |
Microsoft
MSFT
|
+$85M |
Top Sells
| 1 |
UnitedHealth
UNH
|
+$105M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$96.7M |
| 3 |
Exelon
EXC
|
+$92.4M |
| 4 |
J.M. Smucker
SJM
|
+$62.4M |
| 5 |
Tractor Supply
TSCO
|
+$61M |
Sector Composition
| 1 | Technology | 28.66% |
| 2 | Healthcare | 17.31% |
| 3 | Financials | 10.36% |
| 4 | Consumer Discretionary | 9.98% |
| 5 | Industrials | 9.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
901
Assurant
AIZ
$10.6B
| $993K | ﹤0.01% |
5,950
-86
| -1% | -$14.4K |
|
902
ImmunityBio
IBRX
$2.38B
| $993K | ﹤0.01% |
196,200
| – | – |
|
903
Fox Class B
FOX
$22.6B
| $985K | ﹤0.01% |
36,235
+1,041
| +3% | +$28.3K |
|
904
DraftKings
DKNG
$22.7B
| $984K | ﹤0.01% |
27,630
-153
| -0.6% | -$5.45K |
|
905
4D Molecular Therapeutics
FDMT
$322M
| $966K | ﹤0.01% |
+46,000
| New | +$966K |
|
906
Dole
DOLE
$1.29B
| $962K | ﹤0.01% |
77,162
-56,000
| -42% | -$698K |
|
907
Liberty Global Class C
LBTYK
$3.98B
| $955K | ﹤0.01% |
52,868
+1,823
| +4% | +$32.9K |
|
908
FirstService
FSV
$9.36B
| $950K | ﹤0.01% |
5,891
+538
| +10% | +$86.8K |
|
909
Murphy USA
MUSA
$7.42B
| $946K | ﹤0.01% |
2,664
-226
| -8% | -$80.3K |
|
910
Park Hotels & Resorts
PK
$2.35B
| $945K | ﹤0.01% |
60,679
-12,991
| -18% | -$202K |
|
911
AngloGold Ashanti
AU
$32.8B
| $936K | ﹤0.01% |
50,000
-5,500
| -10% | -$103K |
|
912
Reinsurance Group of America
RGA
$12.6B
| $935K | ﹤0.01% |
5,797
| – | – |
|
913
Varonis Systems
VRNS
$6.38B
| $932K | ﹤0.01% |
20,500
| – | – |
|
914
Tenable Holdings
TENB
$3.69B
| $931K | ﹤0.01% |
20,000
-12,000
| -38% | -$559K |
|
915
Supernus Pharmaceuticals
SUPN
$2.54B
| $926K | ﹤0.01% |
31,775
| – | – |
|
916
Edgewise Therapeutics
EWTX
$1.58B
| $920K | ﹤0.01% |
80,000
| – | – |
|
917
Pacira BioSciences
PCRX
$1.16B
| $918K | ﹤0.01% |
27,515
| – | – |
|
918
Premier
PINC
$2.22B
| $916K | ﹤0.01% |
42,100
-11,500
| -21% | -$250K |
|
|
INBX
919
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $916K | ﹤0.01% |
26,400
| – | – |
|
920
Bloom Energy
BE
$14.8B
| $906K | ﹤0.01% |
58,517
+2,379
| +4% | +$36.8K |
|
921
Agios Pharmaceuticals
AGIO
$2.05B
| $901K | ﹤0.01% |
40,000
| – | – |
|
922
EXL Service
EXLS
$6.96B
| $900K | ﹤0.01% |
29,530
-28,245
| -49% | -$861K |
|
923
Cousins Properties
CUZ
$4.82B
| $895K | ﹤0.01% |
36,511
| – | – |
|
924
Erie Indemnity
ERIE
$17.3B
| $891K | ﹤0.01% |
2,706
-228
| -8% | -$75.1K |
|
925
EQT Corp
EQT
$32.4B
| $873K | ﹤0.01% |
22,564
+2,201
| +11% | +$85.2K |
|